ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 4.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -99.8% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -94.6% | 2,000 | -97.1% | 0.00% | -100.0% |
| Q4 2021 | $74,000 | -1.3% | 70,122 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $75,000 | -45.7% | 66,222 | -49.0% | 0.00% | -50.0% |
| Q2 2021 | $138,000 | -6.1% | 129,881 | -13.8% | 0.01% | -14.3% |
| Q1 2021 | $147,000 | +600.0% | 150,743 | +208.6% | 0.01% | – |
| Q4 2020 | $21,000 | +110.0% | 48,850 | -4.4% | 0.00% | -100.0% |
| Q3 2020 | $10,000 | +150.0% | 51,100 | +5577.8% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 900 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |